Amedisys, Inc. (NASDAQ:AMED) Q4’10 EPS EXCEEDS EXPECTATIONS, BUT 2011 GUIDANCE COMES UP SHORT

Amedisys, Inc. (NASDAQ:AMED) reported adjusted fourth fiscal quarter EPS of $0.95 versus consensus of $0.91 on revenues of $394 million yesterday. The company reported net income of $22.1 million or 77 cents a share during the fourth fiscal quarter, down $15.7 or 41.5% from $37.8 million or $1.35 a share in 2009. On an adjusted basis, the company earned 95 cents a share, beating the analysts' expectation by 4 cents. The company also reported a decrease of $11.2 or 2.8% in its net service revenue of $394.3 million during the quarter from $405.5 million in 2009, missing the street estimate of $400.1 million. EBIT margins in the hospice segment were 26.9% in the latest quarter, up from 17.7% in the third quarter and 19.9% during the first three quarters of 2010. The average revenue per completed episode in the home health segment was $3,294 in the fourth quarter, which was flat on a sequential basis despite rate pressures. Same store agencies decreased $8.0 million and $11.5 million of the decrease related to agencies closed during the year offset by $8.3 million in revenue related to start-up and acquisition agencies. The Company announced that it expects 2011 earnings of $3.00 to $3.30 per share on revenue of $1.60 billion to $1.65 billion. Analysts on an average were expecting to post earnings of $3.32 per share on revenue of $1.63 billion for the year 2011. Shares of the company went down by 99 cents or 2.60% and closed at $37.09 after opening at $36.48 and trading in the range of $37.09-$38.40. Volume of 0.890 million shares has been traded compared to the daily average of 0.411 million shares. The market capitalization of the stock stands at $1.08 billion with beta of 0.55 and P/E of 8.20. The 52 week range of the stock is $22.82-$64.28. Amedisys, Inc. (Amedisys) is a provider of home health services to the chronic, co-morbid, aging American population. The Company operates in two segments: home health and hospice segments. Disclaimer: The assembled information distributed by epicstockpicks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Epicstockpicks.com does expect that investors will buy and sell securities based on information assembled and presented herein. EpicStockPicks.com will not be responsible in any way for or accept any liability for any losses arising from an investor's reliance on or use of information obtained from our website or emails. PLEASE always do your own due diligence, and consult your financial advisor.
Negocioenlinea
tdp2664
Epic Stock Picks